Bone Biologics Corp 10-K Cybersecurity GRC - 2024-02-21

Page last updated on April 11, 2024

Bone Biologics Corp reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2024-02-21 17:05:59 EST.

Filings

10-K filed on 2024-02-21

Bone Biologics Corp filed an 10-K at 2024-02-21 17:05:59 EST
Accession Number: 0001493152-24-007432

Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!

Item 1C. Cybersecurity.

Item 1C. Cybersecurity Risk Management and Strategy We have established policies and processes for assessing, identifying, and managing material risk from cybersecurity threats, and have integrated these processes into our overall risk management systems and processes. We monitor cybersecurity threats, including any potential unauthorized occurrence on or conducted through information systems that we use through third party providers that may result in adverse effects on the confidentiality, integrity, or availability of any information residing therein. We require each third-party service provider to certify that it has the ability to implement and maintain appropriate security measures, consistent with all applicable laws, to implement and maintain reasonable security measures in connection with their work with us, and to promptly report any suspected breach of its security measures that may affect our company. We have not encountered cybersecurity challenges that have materially impaired our operations or financial standing. 43 Governance One of the key functions of our Board of Directors is informed oversight of our risk management process, including risks from cybersecurity threats. Our Board of Directors is responsible for monitoring and assessing strategic risk exposure, and our executive officers are responsible for the day-to-day management of the material risks we face. Our Board of Directors administers its cybersecurity risk oversight function directly as a whole. Our Chief Executive Officer and Chief Financial Officer are primarily responsible to assess and manage our material risks from cybersecurity threats. Our Chief Financial Officer oversees our cybersecurity policies and processes, including those described in Risk Management and Strategy above. Under such policies and processes, our Chief Financial Officer is responsible for reporting to our Board of Directors regarding any cybersecurity incidents.


Company Information

NameBone Biologics Corp
CIK0001419554
SIC DescriptionOrthopedic, Prosthetic & Surgical Appliances & Supplies
TickerBBLG - NasdaqBBLGW - Nasdaq
Website
CategoryNon-accelerated filer
Smaller reporting company
Fiscal Year EndDecember 30